Editorial Board ::: Current Enzyme Inhibition

ISSN: 1875-6662 (Online)
ISSN: 1573-4080 (Print)

Volume 13, 3 Issues, 2017

Download PDF Flyer

Current Enzyme Inhibition

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Professor Claudiu T. Supuran
University of Florence, Neurofarba Department
Sesto Fiorentino (Firenze)

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board


Professor Claudiu T. Supuran (Biography
Professor Claudiu T. Supuran

CLAUDIU T. SUPURAN is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).


University of Florence, Neurofarba Department
Sesto Fiorentino (Firenze)


D. Hadjipavlou-Litina (Biography
D. Hadjipavlou-Litina

Professor Dimitra Hadjipavlou-Litina received her undergraduate training in Pharmacy at Aristotle University of Thessaloniki, Greece (1975-1979) and her PhD in Pharmacy at the same University. She conducted postdoctoral studies at California (supervisor Professor Corwin Hansch). Currently she is a full professor and a head at the School of Pharmacy.

Her research interests involve synthesis and biological studies and the use of Computational Chemistry in Drug Design and resulted in the publication of over 220 peer-reviewed articles over 5000 citations and h factor = 38. Currently is the Editor of this journal (Current Enzyme Inbibition, CEI), published by Bentham Science Publishers.


Aristotle University of Thessaloniki

Associate Editors:

A.M. Alafeefy (Biography
A.M. Alafeefy

Ahmed M Alafeefy got his PhD, Pharmaceutical Chemistry, in 2005 from Egypt and left to Saudi Arabia. His current research interest covers the development of potential drugs to combat cancer and viral diseases. He has been consistently working to locate biochemical rationale which enables the preparation of antitumor drugs focusing on qualitative differences between normal and cancerous cells. The complimentary development of semisynthetic biologically active small molecules as antiviral, anticancer agents is his future aim. Currently, he is an Assoc. Prof. of Pharmaceutical Chemistry Kulliyyah of Science, IIUM, Malaysia. He has published more than 40 papers in reputed journals.


Prince Sattam Bin Abdulaziz University
Saudia Arabia

M.A. Ilies (Biography
M.A. Ilies

Dr. Marc A. Ilies was born and educated in Romania, receiving his PhD in 2001 with Professor Alexandru T. Balaban, from C. D. Nenitzescu’s Department of Organic Chemistry of Polytechnic University of Bucharest. After post-doctoral studies Texas A&M University and University of Pennsylvania he joined the Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, where he is currently Associate Professor and an affiliated member of Moulder Center for Drug Discovery Research. His research interests fit within the broadly-defined medicinal chemistry/chemical biology of membrane interfaces, being focused on the development of chemical solutions for the efficient and selective delivery of drugs and nucleic acids for therapeutic purposes.


Temple University
Philadelphia, PA

F. Carta (Biography
F. Carta

Fabrizio Carta received his degree in 2002 in Pharmaceutical Chemistry and Technology from the University of Sassari (IT). On 2008 he received his Ph.D. in Chemistry at the School of Chemistry of the Bristol University (UK), was appointed as postdoctoral fellow at MIT (USA) and finally joined Prof. Scozzafava’s and Supuran’s groups at the University of Florence (IT). Among others he is Editorial Board Member di Journal of Enzyme Inhibition and Medicinal Chemistry (JEIMC) and Journal of the Turkish Chemical Society, Section A: Chemistry (JOTCSA). Co-author of 100 publications on peer-reviewed international journals, 3 book chapters. 4 patents.


University of Florence

S. Poulsen (Biography
S. Poulsen

Sally-Ann Poulsen is Professor at the Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Australia. Her current research encompasses medicinal chemistry, chemical biology and native state mass spectrometry. This research harnesses the chemistry of small molecules as tools to address human disease. She has a PhD in medicinal chemistry and has been the recipient of a Royal Society/NHMRC Howard Florey Research Fellowship at the University of Cambridge, an Australian Research Council (ARC) QEII Fellowship and an ARC Future Fellowship at Griffith University. In 2013 Prof Poulsen was appointed to Chair of Compounds Australia, Australia’s only dedicated compound management facility supporting drug discovery. Since 2013 she has been the Queensland State Representative of the Royal Australian Chemical Institute - Medicinal Chemistry & Chemical Biology Division.


Griffith University

P. Gratteri (Biography
P. Gratteri

Prof. Gratteri earned her PhD in Medicinal Chemistry at the University of Firenze in 1992. She was a postdoctoral fellow at the University of Aix-Marseille III—Laboratoire de la Methodologie de la Recherche Experimentale. Assistant professor in 1992-2001, currently she is associate professor of Medicinal Chemistry – University of Firenze. Her research interests are in the areas of development and application of bioinformatics and computational procedures applied to the evaluation and study of the mechanism underlying target/ligand recognition processes.


University of Florence

A.B. Vermelho (Biography
A.B. Vermelho

Dr Alane Beatriz Vermelho is Biologist, MSc and Dsc in Sciences (Microbiology) at the Federal University of Rio de Janeiro, Brazil, where she is a professor of the Department of General Microbiology and coordinates the Laboratory of Biotechnology Network BIONOVAR - Biocatalysis, Bioproducts and Bioenergy Unit. She Develops research with enzymes and other microbial bioproducts aimed at the Industrial Sector. She is currently Director of the Microbiology Institute Paulo de Góes, UFRJ. She is co-founder of the biotechnological spin off base HANA BIOCOSMETIC


University of Rio de Janeiro
Rio de Janeiro

Editorial Board Members:

Z.A. ALOthman (Biography
Z.A. ALOthman

Zeid A. ALOthman, Professor of Chemistry, at Chemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia. He obtained his Ph.D. in chemistry at Oklahoma State University in 2006.

He is working on a variety of topics ranging from the high surface area materials, Water treatment and production, Ion exchanger, separation and Environmental studies.

He is the group leader of Advanced Materials and Chromatography Group and the supervisor of the Advanced Materials Research Chair.

He supervised seven PhD students and more than 12 master students.

He is an author and co-author of more than 350 scientific publications, three books and six patents.


Chemistry Department, King Saud University
Saudi Arabia

C. Capasso (Biography
C. Capasso

Clemente Capasso is researcher at the National Research Council. His research interest from 1992 to date has been the study of the structure/function relationship of both native and recombinant proteins from terrestrial, marine organisms and pathogenic microorganisms This allowed him to acquire extensive knowledge of most protein purification procedures as well as kinetic, chemical–physical and structural characterization of enzymes. He has written 13 book chapters and published over 100 papers. He acquired an intense training in Italian and international laboratories. He is the Associate Editor of Journal of Enzyme Inhibition and Medicinal Chemistry, and is in the Editorial Board of the journal Expert Opinion on Therapeutic Patents.


Piazzale Aldo Moro
Naples, Rome

R. Costi (Biography
R. Costi

Dr. Roberta Costi obtained a doctorate (PhD) in Medicinal Chemistry from University of Rome “Sapienza”. Currently, Dr. Costi is Associate Professor in Medicinal Chemistry at Dipartimento di Chimica e Tecnologie del Farmaco, University of Rome “Sapienza”. She is the author of more than 100 scientific publications, 80 communications and 2 patents in the field of antiviral, antifungal, antimycobacterial, antitumor (inhibitors of mammalian terminal transferase), and CNS agents (MAO inhibitors; anti-Alzheimer agents). She developed also chemical tools useful to study epigenetic targets. Dr. Costi has extensive experience in heterocyclic chemistry, with particular focus on pyrrole annulated heterocyclic systems.


“Sapienza" University of Rome

I. Glucin (Biography
I. Glucin

Prof. Dr. İlhami GÜLÇİN obtained a doctorate (Ph.D.) in Chemistry from the Ataturk University of Erzurum, Turkey. He is the member of Turkish Academy of Sciences (TÜBA). He has experience in the research of enzyme purification, enzyme inhibition, antioxidant activity, and biological activities. He has also published more than 200 scientific publications. His manuscripts have more than 9000 citations.


Ataturk University

M. Krasavin (Biography
M. Krasavin

Mikhail Krasavin is a Professor of synthetic organic and medicinal chemistry at Saint Petersburg State University (Russia). Prior to assuming this post in 2014, he spent over 10 years in positions of increasing responsibility in pharmaceutical industry (Millennium Pharmaceuticals, Abbott Bioresearch Center, ChemDiv, Inc.) , where he was involved in multiple drug discovery programs in the areas of oncology, metabolic disease, infectious disease and CNS disorders. In 2011-2013 Dr. Krasavin led an independent research group at Eskitis Institute for Drug Discovery (Griffith University) in Braisbane, Australia. Prof. Krasavin has authored more than 100 manuscripts, 8 patents, several book chapters and has consulted various drug discovery and development business entities. In 2016, he was elected a Professor of the Russian Academy of Sciences.


Univ. of St. Petersburg
Saint Petersburg

S. Sengupta
Heritage Institute of Technology

S. Suzen (Biography
S. Suzen

Prof. Sibel Süzen studied at Ankara University, from where she received her Pharmacy degree and master degree in Pharmaceutical Chemistry. She obtained a PhD (1997) from University of Swansea, Chemistry Department, UK. She has been involved in several medicinal chemistry projects related development of aldose reductase inhibitory compounds, synthesis of antioxidant compounds, evaluation of biologically active indole-based melatonin analogues, and investigation of in-vitro drug metabolisms by electroanalytically. She is the author of numerous original research papers, reviews, and book chapters. She is currently Professor of Pharmaceutical Chemistry at Faculty of Pharmacy, Ankara University.


Ankara University

D.J. Timson
University of Birmingham

A. Akdemir (Biography
A. Akdemir

Dr. Akdemir obtained his PhD and MSc from the Department of Pharmaceutical Sciences (VU University Amsterdam, The Netherlands). His research interests are mainly molecular modelling and molecular pharmacology studies of various drug targets (including carbonic anhydrases and nicotinic acetylcholine receptors). He is currently associate professor of pharmacology and vice-dean at the Faculty of Pharmacy (Bezmialem Vakif University, Istanbul, Turkey).


Bezmialem Vakif University
Fatih, Istanbul

S. Carradori (Biography
S. Carradori

Dr. Simone Carradori obtained his Ph.D. in Pharmaceutical Sciences from Sapienza University of Rome (Italy). Currently, he is assistant professor of Medicinal Chemistry at the Department of Pharmacy of “G. D’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is mainly focused on the characterization and synthesis of novel synthetic and natural derivatives with potential biological activity and is documented from about 94 papers in international peer-reviewed journals and one patent.


Department of Pharmacy of “G. D’Annunzio”, University of Chieti-Pescara

S. Durdagi
Bahcesehir University

A.A. Kamnev (Biography
A.A. Kamnev

Professor Alexander A. Kamnev obtained his PhD (1992) and DSc in physical chemistry (2002) from Saratov State University, Saratov, Russia. Currently he is a Leading Scientist at the Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (Saratov, Russia), where he has been working since 1992. His research has been focused on the application of spectroscopic techniques in studying bio(macro)molecules, biocomplexes, supramolecular structures and microbial cells; functionalised plasmonic nanoparticles; bioanalytical applications of vibrational (FTIR, Raman) and Mössbauer spectroscopies. Professor Kamnev has published over 130 scientific papers in peer-refereed international journals. He is a member of Editorial Boards of several specialised scientific journals including Spectrochimica Acta Part A (“Elsevier”) and Current Enzyme Inhibition (“Bentham Science Publishers”).


Institute of Biochemistry and Physiol. of Plants and Microorganisms
Russian Academy of Sciences

M. Mori (Biography
M. Mori

Dr. Mattia Mori obtained his degree in Medicinal Chemistry and his PhD in Structural Biology from the University of Florence, Italy. Currently he is researcher at the Center for Life Nano Science@Sapienza of the Istituto Italiano di Tecnologia (IIT) in Roma, Italy. The research activity of Dr. Mori focuses on medicinal chemistry and drug discovery, with a particular dedication to the use of computer simulations to discover and develop bioactive small molecules, or to study the conformational space of target proteins. Dr. Mori is co-author of more than 45 papers and 1 patent.


Italian Institute of Technology

S. Singh (Biography
S. Singh

Dr. Shalini Singh is presently working as an Assistant Professor in the Department of Chemistry, Bareilly College, Bareilly (U.P.) India. She holds a Ph.D. from A.P.S. University Rewa, (M.P). She has got awards and rewards of an unending sequence like Recipient of D.S.T. Women Scientist Scheme Award (WOS-A), U.G.C. Research Awardee 2011, Recipient of Indian Chemical Society Award-2012 Dr. Singh has contributed 42 research papers of repute with high impact factor Journal. Singh is Fellow member of Indian Chemical Society Kolkatta, India. Dr Singh is also member of many prestigious Editorials boards of national and international repute like Journal of Enzyme Inhibition and Medicinal Chemistry.


Department of Chemistry, Bareilly College
Bareilly (U.P)

H. Terenzi (Biography
H. Terenzi

Hernán Terenzi received his Ph.D. in Biochemistry from Universidade de São Paulo, São Paulo, Brazil (1993). After postdoctoral training at the Institut Pasteur, Paris, France, he returned to Brazil to the Universidade Federal de Santa Catarina as an adjunct professor (1998) and is currently Full Professor of Biochemistry. The Terenzi laboratory studies structure/function relationships in phosphatases and also bioinorganic models of metalloenzymes. Current projects address the development of tyrosine phosphatase inhibitors and mechanisms of activity modulation, as well as the search for novel metal artificial hydrolases. He is a research fellow from the National Council for Scientific and Technological Development (CNPq).


Universidade Federal De Santa Catarina

D. Vullo (Biography
D. Vullo

Dr. Daniela Vullo obtained her Ph.D. in Chemistry at the University of Florence, Italy. Currently, she has a post-doc position at the same university, Department of Chemistry “Ugo Shiff” under the supervision of Prof. Andrea Scozzafava and Prof. Claudiu T. Supuran. The scientific research is focused on enzyme activity characterization, mainly carbonic anhydrase inhibitors and activators and resulted in the publication of over 280 papers with Hirsch factor h=51 and 9112 citations.


Univ. of Florence

V. Beniwal
Maharishi Markandeshwar University

P.A. Colinas (Biography
P.A. Colinas

Dr Colinas received his Ph.D. in chemistry from the Universidad Nacional de La Plata (Argentina) en 1997. He then worked as postdoctoral fellow in the Institut für Organische Chemie, Universität Stuttgart (Germany). In 2006 he became Adjunct Professor of organic chemistry in the Universidad Nacional de La Plata. Since 2005 he is member of the Scientific Research Career of CONICET (Argentina). He has published more than 40 scientific publications. His research interests include carbohydrate chemistry, design of enzyme inhibitors and medicinal chemistry.


Investigador Independiente (CONICET), LADECOR
1900 La Plata

M. Ferraroni
University of Florence
Sesto Fiorentino

A. Karioti
Aristotle University

D. Poirier (Biography
D. Poirier

Dr. Donald Poirier received his basic training in organic chemistry (PhD at Université Laval, 1980-1985) and subsequently specialized in medicinal chemistry and endocrinology (Post-doctorat at CHUL - Research Center, 1986-1990). Professor at Université Laval since 1991, he is especially interested in the development of inhibitors of steroidogenic enzymes (steroid sulfatase and 17β-HSDs types 1, 2, 3, 7 and 12) and antitumor agents for the treatment of different diseases (breast, prostate and leukemia cancers, endometriosis, osteoporosis and Alzheimer). He is also interested to additional aspects of organic chemistry (synthesis, solid-phase synthesis, new methodologies, NMR analysis, etc.) and medicinal chemistry (SAR and QSAR analysis, molecular modeling, biological assays, etc.). He has published 204 scientific publications and 9 patent applications.


CHUQ and Universsite Laval

M.A. Sogorb (Biography
M.A. Sogorb

I am a Faculty Professor of Toxicology at Miguel Hernández University (Spain). I started my research career in biochemical Toxicology with the characterization of enzymes involved in the detoxication of organophosphorus insecticides. At the same time I was involved in the characterization of Neuropathy Target Esterase (an esterase target of organophosphorus insecticides) in in vitro cellular models. I performed a postdoctoral stay (2 years) at the Texas A&M University where I was involved the generation and characterization of mutant bacterial phosphotriesterases by site-directed mutagenesis for enhancing and modulating their catalytic efficacy. Nowadays my records include 59 papers in peer-review journals and 8 book chapters.


University Miguel Hernández

S. Thibaudeau (Biography
S. Thibaudeau

Sébastien Thibaudeau is professor of organic chemistry at the University of Poitiers. He completed his MD and PhD in Poitiers (France) and a fellowship at chemistry department in Oxford University (UK). He is head of the superacid group in the organic synthesis team of the Institute of Chemistry of Poitiers (IC2MP). His current research is mainly focused on the use of superacid activation in organic and bio-organic chemistry.


University of Poitiers


Related Journals

Related eBooks

Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science